LONG-TERM ADMINISTRATION OF CORTICOSTEROIDS IN MYASTHENIA GRAVIS.MANN JD; JOHNS TR; CAMPA JF et al.1976; NEUROLOGY; U.S.A.; DA. 1976; VOL. 26; NO 8; PP. 729-740; BIBL. 39 REF.Article

CORTICOSTEROIDS: A DIRECT EFFECT AT THE NEUROMUSCULAR JUNCTION = CORTICOSTEROIDES: UNE ACTION DIRECTE A LA JONCTION NEUROMUSCULAIREWILSON RW; WARD MD; JOHNS TR et al.1974; NEUROLOGY; U.S.A.; DA. 1974; VOL. 24; NO 11; PP. 1091-1095; BIBL. 39REF.Article

SINGLE-FIBER ELECTROMYOGRAPHY IN MYASTHENIA GRAVISSANDERS DB; HOWARD JF JR; JOHNS TR et al.1979; NEUROLOGY; USA; DA. 1979; VOL. 29; NO 1; PP. 68-76; BIBL. 15 REF.Article

EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IN RATS. MODIFICATION BY THYMECTOMY AND PREDNISOLONE.SANDERS DB; JOHNS TR; ELDEFRAWI ME et al.1977; ARCH. NEUROL.; U.S.A.; DA. 1977; VOL. 34; NO 2; PP. 75-79; BIBL. 36 REF.Article

REDUCTION OF MINIATURE END-PLATE POTENTIAL AMPLITUDE IN EXTRAOCULAR AND LIMB MUSCLES IN AN ANIMAL MODEL OF MYASTHENIA GRAVISZAHM DS; KIM YI; LIU HH et al.1983; EXPERIMENTAL NEUROLOGY; ISSN 0014-4886; USA; DA. 1983; VOL. 80; NO 1; PP. 258-262; BIBL. 17 REF.Article